PE-backed New England Peptide appoints CEO and CFO
New England Peptide, which is backed by Ampersand Capital Partners, has named Dr. Martina Diekmann as CEO and David Gavlik as chief financial officer.
5 March 2020•3 mins read
New England Peptide, which is backed by Ampersand Capital Partners, has named Dr. Martina Diekmann as CEO and David Gavlik as chief financial officer.
Falfurrias hires Great Hill’s Greg Stewart to help lead tech, services deals
3 November 2026 · 1 min read
EIV’s Kristin Kelly: From aspiring vet to energy investor
3 November 2026 · 5 mins read
Permira hires former S&P Global CEO Douglas Peterson as senior adviser
2 November 2026 · 2 mins read
o15 Capital Partners hires Capital One’s Rochelle Probst as managing director
29 October 2026 · 1 min read
HighPost Capital hires Quail Ridge founder Ron Sylvestri as managing director, marketing
28 October 2026 · 1 min read
Broad Sky Partners hires ex-Partners Group investor Henry Elefter as managing director
28 October 2026 · 2 mins read
HarbourVest names ex-Hamilton Lane executive Peter Larsen head of infrastructure distribution
27 October 2026 · 1 min read
